These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 19681875)

  • 1. Quality of life evaluation in epidermolysis bullosa (EB) through the development of the QOLEB questionnaire: an EB-specific quality of life instrument.
    Frew JW; Martin LK; Nijsten T; Murrell DF
    Br J Dermatol; 2009 Dec; 161(6):1323-30. PubMed ID: 19681875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life in patients with epidermolysis bullosa.
    Tabolli S; Sampogna F; Di Pietro C; Paradisi A; Uras C; Zotti P; Castiglia D; Zambruno G; Abeni D
    Br J Dermatol; 2009 Oct; 161(4):869-77. PubMed ID: 19624546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life in epidermolysis bullosa: Validation of the Dutch QOLEB questionnaire and assessment in the Dutch population.
    Yuen WY; Frew JW; Veerman K; van den Heuvel ER; Murrell DF; Jonkman MF
    Acta Derm Venereol; 2014 Jul; 94(4):442-7. PubMed ID: 24337132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life measurements in epidermolysis bullosa: tools for clinical research and patient care.
    Frew JW; Murrell DF
    Dermatol Clin; 2010 Jan; 28(1):185-90. PubMed ID: 19945634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hindi translation and validation of quality of life score in Indian patients with epidermolysis bullosa; and its correlation with the clinical severity assessment scores: A cross-sectional study.
    Bishnoi A; Manjunath S; Kishore K; De D; Handa S; Murrell DF; Mahajan R
    Indian J Dermatol Venereol Leprol; 2022; 88(2):177-183. PubMed ID: 34491666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a disease-specific quality of life questionnaire for gastro-oesophageal reflux disease: the GERD-QOL questionnaire.
    Chan Y; Ching JY; Cheung CM; Tsoi KK; Polder-Verkiel S; Pang SH; Quan WL; Kee KM; Chan FK; Sung JJ; Wu JC
    Aliment Pharmacol Ther; 2010 Feb; 31(3):452-60. PubMed ID: 19878152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development, reliability, and validity of a novel Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI).
    Loh CC; Kim J; Su JC; Daniel BS; Venugopal SS; Rhodes LM; Intong LR; Law MG; Murrell DF
    J Am Acad Dermatol; 2014 Jan; 70(1):89-97.e1-13. PubMed ID: 24355263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Family Dermatology Life Quality Index: measuring the secondary impact of skin disease.
    Basra MK; Sue-Ho R; Finlay AY
    Br J Dermatol; 2007 Mar; 156(3):528-38. PubMed ID: 17300244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translation, cross-cultural adaptation and validation of the Quality of Life Evaluation in Epidermolysis Bullosa instrument in Brazilian Portuguese.
    Cestari T; Prati C; Menegon DB; Prado Oliveira ZN; Machado MC; Dumet J; Nakano J; Murrell DF
    Int J Dermatol; 2016 Feb; 55(2):e94-9. PubMed ID: 26474322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of an Asthma-Specific Quality of Life (A-QOL) questionnaire.
    Lee EH; Kim SH; Choi JH; Jee YK; Nahm DH; Park HS
    J Asthma; 2009 Sep; 46(7):716-21. PubMed ID: 19728212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes and patient-based hearing status in conductive hearing loss.
    Stewart MG
    Laryngoscope; 2001 Nov; 111(11 Pt 2 Suppl 98):1-21. PubMed ID: 11802001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of the BD-QoL: a quality of life measure specific to Behçet's disease.
    Gilworth G; Chamberlain MA; Bhakta B; Haskard D; Silman A; Tennant A
    J Rheumatol; 2004 May; 31(5):931-7. PubMed ID: 15124253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot quality-of-life instrument for pruritus.
    Desai NS; Poindexter GB; Monthrope YM; Bendeck SE; Swerlick RA; Chen SC
    J Am Acad Dermatol; 2008 Aug; 59(2):234-44. PubMed ID: 18550210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life instrument for Turkish people with skin diseases.
    Gurel MS; Yanik M; Simsek Z; Kati M; Karaman A
    Int J Dermatol; 2005 Nov; 44(11):933-8. PubMed ID: 16336527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEINES-QOL/Sym questionnaire was a reliable and valid disease-specific quality of life measure for deep venous thrombosis.
    Kahn SR; Lamping DL; Ducruet T; Arsenault L; Miron MJ; Roussin A; Desmarais S; Joyal F; Kassis J; Solymoss S; Desjardins L; Johri M; Shrier I;
    J Clin Epidemiol; 2006 Oct; 59(10):1049-56. PubMed ID: 16980144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of an epidermolysis bullosa family/parental burden score.
    Dufresne H; Hadj-Rabia S; Taieb C; Bodemer C
    Br J Dermatol; 2015 Dec; 173(6):1405-10. PubMed ID: 26281012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of the fecal incontinence and constipation quality of life measure in children with spina bifida.
    Nanigian DK; Nguyen T; Tanaka ST; Cambio A; DiGrande A; Kurzrock EA
    J Urol; 2008 Oct; 180(4 Suppl):1770-3; discussion 1773. PubMed ID: 18721959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychometric Properties of the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa patient score (iscorEB-p): a patient-reported outcome measure.
    Salamon G; Strobl S; Field-Werners U; Diem A; Schwieger-Briel A; Pope E
    Br J Dermatol; 2024 Jun; 191(1):75-81. PubMed ID: 38261404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and preliminary validation of a systemic lupus erythematosus-specific quality-of-life instrument (SLEQOL).
    Leong KP; Kong KO; Thong BY; Koh ET; Lian TY; Teh CL; Cheng YK; Chng HH; Badsha H; Law WG; Lau TC; Chew LC; Ho HJ; Pong LY; Hoi LS; Sangeetha N; Chan SP; Howe HS
    Rheumatology (Oxford); 2005 Oct; 44(10):1267-76. PubMed ID: 15797980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Gilles de la Tourette syndrome-quality of life scale (GTS-QOL): development and validation.
    Cavanna AE; Schrag A; Morley D; Orth M; Robertson MM; Joyce E; Critchley HD; Selai C
    Neurology; 2008 Oct; 71(18):1410-6. PubMed ID: 18955683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.